Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Application save search
Nkarta Receives FDA Clearance of IND Application for NKX019 in Lupus Nephritis
Published: 2023-10-17 (Crawled : 11:00) - globenewswire.com
NKTX | $7.78 -1.02% -1.03% 680K
|
Health Technology
|
| O: -0.68%
H: 168.71%
C: 113.61%
nkx019 fda lupus clearance application
TransCode Therapeutics Announces Positive Pre-Clinical Glioblastoma Results with Lead Therapeutic Candidate, TTX-MC138Further Supports TTX-MC138 Application in Brain Cancer
Published: 2023-09-25 (Crawled : 17:00) - biospace.com/
RNAZ | $0.5195 3.59% 3.46% 270K
|
Professional, Scientific, and T...
|
| O: 97.29%
H: 144.27%
C: 94.66%
mc138 ttx-mc138 pre-clinical positive cancer application therapeutics results glioblastoma
Scopus BioPharma Announces FDA Approval of IND Application for Lead Drug Candidate
Published: 2021-05-24 (Crawled : 14:00) - globenewswire.com
SCPS | $0.1682
|
|
| O: -3.69%
H: 247.56%
C: 78.57%
fda biopharma fda approval drug approval application
Vincerx Pharma Announces FDA Safe to Proceed Letter for Investigational New Drug (IND) Application for its αVβ3 Small Molecule-Drug Conjugate (SMDC) VIP236
Published: 2022-12-13 (Crawled : 19:00) - biospace.com/
VINC | $0.8967 -5.63% -5.97% 530K
|
|
| O: 7.22%
H: 54.99%
C: 48.13%
vip236 fda pharma drug application
Chairman of Intelligent Living Application Group Issues New Year's Open Letter to Shareholders
Published: 2023-01-03 (Crawled : 15:20) - prnewswire.com
ILAG | $0.4547 6.84% 6.4% 91K
|
|
| O: 3.39%
H: 105.54%
C: 47.29%
application living group
Outlook Therapeutics Provides Update on Biologics License Application (BLA) Submission for ONS-5010 as a Treatment for Wet AMD
Published: 2022-05-31 (Crawled : 12:20) - globenewswire.com
OTLK P | $8.285 -3.78% -3.92% 230K
|
Health Technology
|
| O: -48.46%
H: 60.24%
C: 43.97%
ons-5010 treatment application license therapeutics submission
Pineapple Financial Inc. Introduces Simplified Online Mortgage Application for Borrowers
Published: 2023-12-06 (Crawled : 13:00) - prnewswire.com
PAPL | $1.68 16.67% 0.0% 240K
|
|
| O: 0.0%
H: 71.86%
C: 43.29%
application financial
Nutriband Inc. Issued Full Patent from the Korean Intellectual Property Office for Its “Abuse and Misuse Deterrent Transdermal System” Application
Published: 2021-12-31 (Crawled : 15:00) - nutriband.com
NTRB | $4.18 -2.11% -3.39% 24K
|
Manufacturing
|
| O: 80.31%
H: 72.76%
C: 42.98%
application patent system intel transdermal system
Professional Diversity Network, Inc. Announces Partnership with Phala Network to Develop Privacy-Protecting Blockchain Application
Published: 2020-12-30 (Crawled : 14:00) - globenewswire.com
IPDN | $1.68 -1.75% -1.79% 2.2K
|
Technology Services
|
| O: 40.15%
H: 189.58%
C: 42.71%
blockchain partnership application
Femasys Announces Notice of Allowance for New U.S. Patent Application Covering Use of FemBloc for Female Permanent Birth Control
Published: 2023-07-27 (Crawled : 12:20) - globenewswire.com
FEMY | News | $1.305 0.39% 0.38% 190K
|
Manufacturing
|
| O: 62.09%
H: 77.97%
C: 42.37%
patent control application
Regulus Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) Application for RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Published: 2022-05-11 (Crawled : 13:00) - biospace.com/
RGLS | $2.22 -5.13% -5.41% 200K
|
Health Technology
|
| O: 11.05%
H: 71.96%
C: 40.74%
rgls8429 treatment fda drug disease kidney application therapeutics
Minerva Neurosciences Submits New Drug Application to FDA for Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia
Published: 2022-08-22 (Crawled : 13:20) - biospace.com/
NERV | $2.5 1.21% 1.2% 14K
|
Health Technology
|
| O: 5.96%
H: 57.75%
C: 39.51%
treatment fda drug schizophrenia application roluperidone negative
BrainStorm Cell Therapeutics Receives Refusal to File Letter from FDA for its New Biologics License Application for NurOwn for the treatment of ALS
Published: 2022-11-10 (Crawled : 14:00) - biospace.com/
BCLI | $0.503 -6.99% -7.51% 1.1M
|
Health Technology
|
| O: -58.48%
H: 56.67%
C: 39.17%
nurown treatment fda als application license therapeutics
Ocean Biomedical (NASDAQ: OCEA) Announces Notice of Allowance for U.S. Patent Application for Developing “Whole New Class” of Malaria Therapeutics Issued to Scientific Co-founder Dr. Jonathan Kurtis
Published: 2023-04-13 (Crawled : 12:20) - globenewswire.com
OCEA | $1.87 4.76% 4.55% 210K
|
|
| O: 10.2%
H: 49.09%
C: 36.02%
patent malaria application therapeutics
GBT Received a Notice of Publication for its Microchip Reliability Verification and Auto-Correction, Non-Provisional Patent Application
Published: 2022-11-29 (Crawled : 13:00) - globenewswire.com
GTCH | $0.0001 0.0% 55M
|
Information
|
| O: -12.5%
H: 28.57%
C: 28.57%
patent application publication
CNBX Patent Application "Composition and Method for Treating Cancer with Cannabinoids" Enters National Phase in US and Israel
Published: 2022-10-13 (Crawled : 14:00) - biospace.com/
CNBX | $0.0122 5.88% 280K
|
Manufacturing
|
| O: -5.54%
H: 26.71%
C: 26.71%
patent israel application cancer
Century Therapeutics Receives FDA Clearance of IND Application for CNTY-101 in Systemic Lupus Erythematosus
Published: 2023-12-06 (Crawled : 12:30) - globenewswire.com
IPSC | $2.97 4.58% 4.38% 150K
|
Professional, Scientific, and T...
|
| O: 8.23%
H: 33.92%
C: 25.73%
cnty-101 fda lupus clearance application therapeutics
Kiromic BioPharma Submits Investigational New Drug Application for Phase 1 Trial with Deltacel for Non-Small Cell Lung Cancer
Published: 2023-04-03 (Crawled : 14:00) - biospace.com/
KRBP | $2.3 -90.21% 15K
|
Health Technology
|
| O: 2.07%
H: 29.44%
C: 25.63%
lung drug cancer cell biopharma application trial
Regen BioPharma, Inc. Files Provisional Patent Application on Second Generation Survivin mRNA Cancer Immunotherapy Vaccine
Published: 2022-07-26 (Crawled : 22:00) - prnewswire.com
RGBP | $0.5678 5.69% 2K
|
Manufacturing
|
| O: 5.77%
H: 32.73%
C: 23.64%
patent immunotherapy vaccine application mrna cancer
U.S. District Court Upholds Final Judgment for XIFAXAN(R) 550 mg That Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029
Published: 2023-05-17 (Crawled : 22:00) - biospace.com/
BHC | $8.6 -0.69% 0.0% 2.1M
|
Health Technology
|
| O: 1.0%
H: 40.79%
C: 22.86%
fda drug approval application
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.